Background: Conventional automated hematology analyzers have limitations in platelet measurements such as poor accuracy and precision in the low count range and interference by nonplatelet particles. In order to improve it, the newly developed XN-Series automated hematology analyzers (Sysmex Corporation, Kobe, Japan) have been installed with a new dedicated channel for platelet analysis (PLT-F), which is based on a fluorescence flow cytometry method with uses of a novel fluorescent dye specifically staining platelets. We evaluated the basic performance of this new PLT-F channel.
Methods: Basic performance of the PLT-F channel in within-run reproducibility and assay linearity was studied using standard methods. Correlation was studied between PLT-F and a conventional automated hematology analyzer (XE-2100) and immunoplatelet analysis using anti-CD61 monoclonal antibody (Cell-Dyn Sapphire; Abbott Laboratories). The assay interference by nonplatelet particles such as fragmented red and white blood cells was evaluated by using clinical samples, respectively, from burn injury and acute leukemia.
Results: Basic performance of the PLT-F platelet counting was satisfactory in within-run reproducibility, linearity and correlation with the conventional analyzer. The correlation was satisfactory also with the immunoplatelet analysis, even for samples from a patient with burn injury, and those with white blood cell fragments displayed, platelet abnormal flag and low platelet counts (<50 × 10(9)/l).
Conclusion: The platelet counting performance of the PLT-F channel of the XN Series had improved accuracy and precision in the low range and in abnormal samples, avoiding the interference by nonplatelet particles.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807536 | PMC |
http://dx.doi.org/10.1002/jcla.21691 | DOI Listing |
Background: Irisin is an exercise-induced myokine that elicits beneficial effects of exercise in fat, bone, and the brain. Previous work suggests that extracellular heat shock protein 90a (Hsp90a) mediates irisin-receptor interaction in bone and fat. Despite this, it remains unclear if Hsp90a is necessary for irisin signaling in the brain.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Siemens Heathineers, Princeton, NJ, USA.
Background: The recent breakthrough in monoclonal antibody treatment for Alzheimer's disease (AD) has ushered in a new phase in AD healthcare. However, associated amyloid-related imaging abnormalities (ARIA) present a significant risk to patients, necessitating careful monitoring. Detection by radiologists can be challenging and may suffer from inconsistency.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Minnesota Duluth, Duluth, MN, USA.
This study was approved by the ethics review board at the University of Minnesota. In conclusion, the successful design and testing of an intelligent living space tailored for dementia care were conducted in a controlled lab environment with healthy participants. The primary aim was to assess the viability of integrating robots, wearable sensors, and spatial technology to support the well-being of individuals affected by dementia.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Kentucky College of Osteopathic Medicine, PikeVille, KY, USA.
Background: Integrating humanoid robots, wearable sensors, and spatial technology into an intelligent dementia-friendly living space is crucial for tailoring personalized and supportive environments, thereby addressing the unique needs of individuals affected by dementia and maintaining quality of life.[1-10].
Methods: We programmed Pepper, a humanoid robot, for independent verbal communication to interact, tell jokes, and offer medications.
Alzheimers Dement
December 2024
Kentucky College of Osteopathic Medicine, PikeVille, KY, USA.
Background: Integrating humanoid robots, wearable sensors, and spatial technology into an intelligent dementia-friendly living space is crucial for tailoring personalized and supportive environments, thereby addressing the unique needs of individuals affected by dementia and maintaining quality of life.[1-10].
Methods: We programmed Pepper, a humanoid robot, for independent verbal communication to interact, tell jokes, and offer medications.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!